Clinuvel Pharmaceuticals | CUV - Operating Profit

Stock Price
9.13
Daily Change
-0.34 -3.59%
Monthly
-0.33%
Yearly
-14.11%
Q2 Forecast
9.29

Clinuvel Pharmaceuticals reported AUD13.51M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -30.96M 11.14M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025